Some articles have not been moved to our new site yet.
As a result you have been redirected to our old site.
If you wish to return to our new site - click here.
 GW
Pharmaceuticals
are not involved in outdoor planting (outdoor plantations
would involve industrial hemp which has been grown
under licence in recent years), and receive advice
from some of the top world experts on cannabis cultivation.
They are breeding plants to be able to produce a reliable
cannabinoid profile (i.e. not just THC) in order to
test different balances for treating conditions such
as pain and MS. The intention is to reduce raw plant
material down to the equivalent of "grass oil",
and dilute this with a carrier liquid for use in inhalers
etc. The cannabinoid balance is important, as cannabidiol
(CBD) shows as much promise as THC therapeutically,
whereas THC appears to be a painkiller, CBD appears
to be an anticonvulsant with a different method of
action, and recent studies have shown it to be neuroprotective
against brain damage following strokes (and possibly,
in theory, against neurodegeneration caused by ecstasy).
CBD is normally found in hashish, with little present
in bush or skunk, and can take the edge off a THC
high, and can make users less anxious and paranoid.
For more
info click here
|
All contents of this
web site & any links to other sites etc, is for educational
& research purposes. IDMU at no time seeks to encourage
illegal activities. All sections of this site and its
contents are protected under copyright laws. © IDMU
Ltd 1994 - 2008 Website
Design by Freelance
Graphics
|
|
|
